Transcription of FY’13 Results
{{id}} {{{paragraph}}}
FY 13 Results2 DISCLAIMERT hese statements are related, among others, to the intent, belief or current expectations of the customer base, estimates regarding future growth in the different business lines and the global business, market share, financial Results and other aspects of the activities and situation relating to the forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and actual Results may differ materially from those expressed in or implied by these forward-looking statements as a result of various factors, many of which are beyond the ability of DiaSorin to control or estimate Company does not undertake to update or otherwise revise any forecasts or objectives presented herein, except in complia
4 2013 MAIn TOpICS Revenues: gRowing as expected (+2.5% at CER) FY’13 guidance achieved: growth between +2% and +4% at CER cLia ex vit d: (+17.6% at ceR) Boosting and sequentially increasing revenues
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}